[Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection].
Implementation of surveillance culture programs and molecular typing are important contributions of Clinical Microbiology to the control of nosocomial infections. This document provides information on collection, transport, preservation, and processing of samples for surveillance culture, as well as the criteria for interpreting and reporting the results of relevant etiologic agents in nosocomial infection. This includes methicillin-resistant Staphylococcus aureus (MRSA), glycopeptide-resistant Enterococcus spp., enterobacteria producing extended-spectrum beta -lactamases (ESBLs), multiresistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa. Details on the available methods for rapid diagnosis are also presented. The information in this document attempts to provide a general approach to the problem and may be considered a starting point for laboratories that are developing their own guidelines, according to needs defined by the multidisciplinary nosocomial infection control team.
Cano
María Eliecer
ME
Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, España.
Domínguez
M Angeles
MA
Ezpeleta
Carmen
C
Padilla
Belén
B
Ramírez de Arellano
Encarnación
E
Martínez-Martínez
Luis
L
D040981:Acinetobacter baumannii / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D003428:Cross Infection / Q000188:drug therapy*; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects / Q000201:enzymology; D016983:Enterococcus / Q000187:drug effects; D006020:Glycopeptides; D006801:Humans; D016106:Methicillin Resistance; D011159:Population Surveillance; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology; D013211:Staphylococcus aureus / Q000187:drug effects; D018440:beta-Lactam Resistance
D006020:Glycopeptides